Vnitr Lek 2007, 53(9):919-922

Jaká je role katetrové ablace A-V junkce a trvalé kardiostimulace v době, kdy lze fibrilaci síní všech forem léčit selektivní katetrovou ablací? - editorial

M. Fiala
Oddělení kardiologie, Kardiocentrum, Nemocnice Podlesí a.s., Třinec, přednosta prim. MUDr. Marian Branny

Received: July 25, 2007; Published: September 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fiala M. Jaká je role katetrové ablace A-V junkce a trvalé kardiostimulace v době, kdy lze fibrilaci síní všech forem léčit selektivní katetrovou ablací? - editorial. Vnitr Lek. 2007;53(9):919-922.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brembilla-Perrot B, Jacquemin L, Houplon P et al. Bradycardia-induced polymorphic ventricular tachycardia after radiofrequency catheter modification of atrioventricular junction. J Interv Card Electrophysiol 1997; 1: 153-155. Go to original source... Go to PubMed...
    2. Brignole M, Gammage M, Puggioni H et al. Comparative assessment of right, left, end biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J 2005; 26: 712-722. Go to original source... Go to PubMed...
    3. Brignole M, Gianfranchi L, Menozzi C et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized, controlled study. Circulation 1997; 96: 2617-2624. Go to original source... Go to PubMed...
    4. Brignole M, Gianfranchi L, Menozzi C et al. Prospective randomized study of atrioventricular ablation and mode switching, dual chamber pacemaker implantation versus medical therapy in drug resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation. Europace 1999; 1: 15-19. Go to original source... Go to PubMed...
    5. Brignole M, Menozzi C, Gianfranchi L et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1997; 96: 2617-2624. Go to original source... Go to PubMed...
    6. Bulková V, Fiala M, Chovančík J et al. Analysis of the cost of therapy in patients with atrial fibrillation in the Czech republic. Giorn Ital Aritmol Cardiostim 2006; 9(Suppl): 88.
    7. Doshi RN, Daoud EG, Fellows C et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005; 16: 1160-1165. Go to original source... Go to PubMed...
    8. Feld GK Polymorphic ventricular tachycardia complicating radiofrequency catheter modification of the AV node for control of rapid ventricular response in atrial fibrillation. J Interv Card Electrophysiol 1997; 1: 157-158. Go to PubMed...
    9. Fiala M, Chovančík J, Neuwirth R et al. Katetrová ablace pro chronickou fibrilaci síní metodou obkružujících a komplexních lineárních lézí v levé srdeční síni: ukončení arytmie při ablaci a dlouhodobé klinické výsledky. Vnitř Lék 2007; 53: 231-241. Go to PubMed...
    10. Grogan M, Smith HC, Gersh BJ et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardimyopathy. Am J Cardiol 1992; 69: 1570-1573. Go to original source... Go to PubMed...
    11. Haïssaguerre M, Hocini M, Sanders P et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: 1138-1147. Go to original source... Go to PubMed...
    12. Hamdan MH, Ramaswamy K, Joglar JA et al. Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation. J Am Coll Cardiol 2000; 36: 151-158. Go to original source... Go to PubMed...
    13. Hsu LF, Jaïs P, Sanders P et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 237-283. Go to original source... Go to PubMed...
    14. Kindermann M, Hennen B, Jung J et al. The Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006; 47: 1927-1937. Go to original source... Go to PubMed...
    15. Leclercq C, Walker S, Linde C et al. Comparative effects of permanent biventricular and right atrial pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-1787. Go to original source... Go to PubMed...
    16. Lee SH, Chen SA, Tai CT et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998; 31: 637-644. Go to original source... Go to PubMed...
    17. Le Heuzey JY, Paziaud O, Piot O et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004; 147: 121-126. Go to original source... Go to PubMed...
    18. Levy T, Walker S, Mason M et al. Importance of rate control of rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left atrial function: a randomized controlled study. Heart 2001; 85: 171-178. Go to original source... Go to PubMed...
    19. Linde C, Braunschweig F, Gadler F et al. Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). Am J Cardiol 2003; 91: 1090-1095. Go to original source... Go to PubMed...
    20. Linde C, Leclercq C, Rex S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002; 40: 111-118. Go to original source... Go to PubMed...
    21. Marshall HJ, Harris ZI, Griffith MJ et al. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing and mode-switch algorithm. Circulation 1999; 99: 1578-1592. Go to original source... Go to PubMed...
    22. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projection for future prevalence. Circulation 2006; 114: 119-125. Go to original source... Go to PubMed...
    23. Neal GK, Ellenbogen KA, Guidici M et al. The APT investigators. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interv Card Electrophysiol 1998; 2: 121-135. Go to original source... Go to PubMed...
    24. Oczan C, Jahangir A, Friedman PA et al. Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 2002; 40: 105-110. Go to original source... Go to PubMed...
    25. Oral H, Chugh A, Özaydin M et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765. Go to original source... Go to PubMed...
    26. Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. The APAF study. J Am Coll Cardiol 2006; 48: 2340-2347. Go to original source... Go to PubMed...
    27. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-197. Go to original source... Go to PubMed...
    28. Reynolds MR, Cohen DJ, Kugelmass AD et al. The frequency and incremental costs of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497. Go to original source... Go to PubMed...
    29. Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006; 27: 216-221. Go to original source... Go to PubMed...
    30. Tsang TS, Petty GW, Barnes ME et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003; 42: 93-100. Go to original source... Go to PubMed...
    31. Ueng KC, Tsai TP, Tsai CF et al. Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response. J Cardiovasc Electrophysiol 2001; 12: 303-309. Go to original source... Go to PubMed...
    32. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugh as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. Go to original source... Go to PubMed...
    33. Weerasooriya R, Davis M, Powell A et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol 2003; 41: 1697-1702. Go to original source... Go to PubMed...
    34. Wolf PA, Benjamin EJ, Belanger AJ et al. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 1996; 131: 790-795. Go to original source... Go to PubMed...
    35. Wyse DG, Waldo AL, DiMarco MC et al. The Atrial Fibrillation Follow up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.